-
Our Mission
Everything we do starts with our Mission: to enable our customers to make the world healthier, cleaner, and safer.
Read More -
Our Mission
Everything we do starts with our Mission: to enable our customers to make the world healthier, cleaner, and safer.
Read More -
Our Mission
Everything we do starts with our Mission: to enable our customers to make the world healthier, cleaner, and safer.
Read More-
- Tackling Crime by Trading Punishment for Treatment
- Customer Stories
- Removing the word serial with rapid DNA
- Turning the tap on without fear
- Second shot at life
- Mission in a Minute
- Creating Empowerment Opportunities in the Veterinary Sciences
- Building hope and affordable homes in Michigan
- Preeclampsia
- This Girl is On Fire
- Counting on You
- Allergy Diagnostic Tests Help Ambitious Tennis Player Get Back in the Game
- Tackling Crime by Trading Punishment for Treatment
- POWER Act Aims to Fund Science-based Technology to Address Opioid Crisis
- Supporting connections that lead to life-saving medical care
- Microbiologist's near-fatal battle with sepsis highlights urgent need for awareness and better treatment protocols
- An Icelandic volcano expedition exploring newly formed lava tubes uncovers insights into Earth's origins.
- How Thermo Fisher Scientific colleagues partner with Ronald McDonald House to support families of pediatric patients
- This is a test
- This is another test for a tutorial!
- Text and Image Demo
- Survivor of domestic violence finds new hope with prosthetic hand
- Thermo Fisher colleagues’ passion to advance HIV clinical trials help make lifesaving therapies a reality
- Clean the World and Thermo Fisher volunteers support communities hard hit by natural disaster
- Thermo Fisher volunteers assemble birthing kits to support underserved mothers and babies
- Life-saving allergy treatment
- Water wise
- Better texture for better batteries
- Lab automation goes viral in honeybee disease research
- How NIH funding transforms organ transplantation
- Thermo Fisher Scientific launches state-of-the-art Advanced Therapies Collaboration Center
- Discovery opens doors for cheaper and quicker battery manufacturing
- Tufts Center study shows integrated drug development services could speed delivery of new therapies to patients up to 3 years faster
- This is a new test
- Thermo Fisher opens the Centre for Advanced Training and Innovative Research to build the next generation of scientists in South Africa
- Thermo Fisher collaboration with Project HOPE helps create opportunities for Nigerian youth
- Thermo Fisher and Rise Against Hunger provide lifesaving support in Haiti
- New Thermo Fisher manufacturing facility boosts U.S. supply chain resilience and creates jobs
- Science and genetic testing buy Stage 4 lung cancer patient 10 more years, and counting
- Thermo Fisher and OpenAI collaboration aims to accelerate clinical trials and enable the delivery of new medicines to patients sooner.
-
Our Mission
Everything we do starts with our Mission: to enable our customers to make the world healthier, cleaner, and safer.
Read More
By Terri Somers
Senior Manager, Global PR and StoryLab
WALTHAM, Mass. (Oct. 16, 2025) Thermo Fisher Scientific Inc., the world leader in serving science, announced a landmark collaboration with OpenAI today to embed advanced artificial intelligence across its clinical trials business — aiming to accelerate drug development, simplify the research processes, and get medicines to patients faster and more cost-effectively.
The collaboration is part of Thermo Fisher’s company-wide AI adoption to further enhance its proven growth strategy, applying cutting-edge tools to speed scientific innovation, enhance productivity, and reduce complexity in numerous processes.
“AI is shaping the future of science. And when combined with our Mission to enable our customers to make the world healthier, cleaner and safer, it is a powerful catalyst to accelerate scientific advancement,” said Marc Casper, Thermo Fisher’s Chairman, President and CEO. “With OpenAI, we’re further embedding AI across our operations, products and services. Together, we’re building an ecosystem that accelerates scientific breakthroughs and delivers impact for patients and society.”
Open AI’s advanced capabilities will initially be deployed to one of the focus areas with the highest impact - Thermo Fisher’s clinical research business, PPD – to significantly improve the cycle time of clinical trials and accelerate the time to bring new medicines to market.
The collaboration will also:
- Combine the expertise and capabilities from both organizations to be applied across Thermo Fisher to more quickly help identify therapies that are unlikely to succeed, so that customers can redirect investment and resources toward more promising opportunities.
- Integrate AI into Thermo Fisher’s Accelerator™ Drug Development solution, spanning early development, Phase I–III clinical research, clinical manufacturing and supply and commercialization, to deliver greater speed, simplicity and scalability for customers.
- Launch frontier AI to Thermo Fisher colleagues, with ChaptGPT Enterprise, making it easier to build confidence and fluency with AI.
“Thermo Fisher plays a massive role in advancing science, and together we have an opportunity to accelerate how medicine can reach more people,” said Brad Lightcap, chief operating officer at OpenAI. “With OpenAI directly powering Thermo Fisher workflows, frontier AI can help cut through complexity, speed up breakthroughs, and bring real impact to patients' lives."